Plain-English translation of NCT06877234 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is an early-stage trial testing a new procedure called the Ultrasonic Nerve Ablation System to treat essential hypertension (high blood pressure that isn't caused by another condition). The procedure uses focused ultrasound waves to reduce nerve activity in the kidneys, which may help lower blood pressure. Researchers want to see if this treatment is safe and effective for people whose high blood pressure hasn't been controlled well by standard medications.
Many people with high blood pressure struggle to control it even while taking two or more medications at full doses. This trial exists to explore whether this new ultrasound-based treatment could offer an additional option for patients like you whose blood pressure remains too high despite medication.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive the ultrasound procedure at one of two research hospitals in China. Before the procedure, you'll have imaging of your kidney arteries (a CTA scan). After the procedure, you'll be checked before leaving the hospital, then return for follow-up visits at 1 month, 2 months, 3 months, and 6 months. During these visits, your blood pressure will be measured and your overall health assessed. Your current blood pressure medications will generally stay the same during the 6 months, though doctors may adjust doses if your blood pressure becomes too high or too low.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
China